Table 10.
Treatment outcomes in non-ECMO group vs ECMO group
| Variable | All (n = 1491) | Non-ECMO group (n = 1389) | ECMO group (n = 92) | p- value |
|---|---|---|---|---|
| Discharge data | ||||
| Microbiological cure (defined as 2 consecutive negative PCR samples for SARS-CoV-2) | 587 (39.4) | 574 (41.3) | 13 (14.1) | 0.000* |
| ICU discharge data | ||||
| At 28 days of ICU stay, the patient was | ||||
| Still in ICU, ventilated | 81 (5.4) | 49 (3.5) | 31 (33.7) | 0.000* |
| Still in ICU, not ventilated | 27 (1.8) | 24 (1.7) | 3 (3.3) | |
| Discharged from ICU | 1310 (87.9) | 1251 (90.1) | 51 (55.4) | |
| Hospital discharge data | ||||
| Transferred to another facility | 99 (6.6) | 89 (6.4) | 10 (10.9) | 0.000* |
| Discharged home alive | 779 (52.3) | 742 (53.4) | 37 (40.2) | |
| Death | 603 (40.4) | 558 (40.2) | 45 (48.9) | |
| Days of hospitalization | 20.8 ± 18.7 (1–152) | 20.2 ± 18.3 (1–152) | 29.1 ± 20.9 (3–108) | 0.000* |
| Days of patient’s stay in ICU | 13.4 ± 13.8 (0–139) | 12.6 ± 13.2 (0–139) | 26 ± 17.1 (3–95) | 0.000* |
| Days of mechanical ventilation | 15 ± 16.5 (1–154) | 14.2 ± 16.5 (1–154) | 22.4 ± 14.4 (2–92) | 0.000* |
| Days taken to be SARS-CoV-2 PCR-negative | 22.3 ± 12.9 (2–85) | 22.2 ± 13.1 (2–85) | 22.2 ± 11.2 (6–46) | 0.998 |
Data are presented as mean ± SD (minimum–maximum), or number (%), unless otherwise indicated
COVID-19 coronavirus disease 2019, ECMO extracorporeal membrane oxygenation, ICU intensive care unit, SARS-CoV-2 severe acute respiratory syndrome coronavirus 2, SD standard deviation
*Represents significant differences
Percentages do not total 100% owing to missing data